Another Heart Drug Fails, Shocking Cardiologists
5 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
"Another Heart Drug Fails, Shocking Cardiologists" is generating significant coverage in the Business category, with 5 articles from 5 distinct sources tracked by PULSE so far.
Outlets currently covering the story include Bloomberg.com, statnews.com, Reuters and Novartis. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.
This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.
Generated by PULSE's extractive engine from coverage metadata only — no AI-written claims. Updated 3h ago.
Quick answers
Why is "Another Heart Drug Fails, Shocking Cardiologists" trending?
Because 5 independent news sources published 5 articles about it in a short window — a coverage burst PULSE classifies as a trend.
How does PULSE measure this trend?
PULSE scores velocity from the rate of new articles weighted by source diversity, snapshotted hourly. The full method is public on our methodology page.
Is this trend still active?
The status badge on this page updates hourly: rising, peaking, cooling, or archived once coverage stops for 48 hours.
Coverage (8)
- Novartis announces Lp(a)HORIZON Phase III topline results GlobeNewswire · 4h ago
- Novartis Says Closely Watched Cholesterol Study Failed to Meet Goal WSJ · 4h ago
- Novartis Says Pelacarsen Heart Disease Drug Missed Primary Endpoint WSJ · 4h ago
- Novartis Drug Fails Key Test for New Heart Disease Approach Bloomberg.com · 5h ago
- Novartis’ experimental cardiovascular drug fails a pivotal study statnews.com · 5h ago
- Ionis, Novartis' key experimental heart drug fails in late-stage trial Reuters · 5h ago
- Novartis announces Lp(a)HORIZON Phase III topline results for pelacarsen in patients with elevated Lp(a) and established cardiovascular disease (CVD) Novartis · 5h ago
- Another Heart Drug Fails, Shocking Cardiologists nytimes.com · 5h ago
Topics
Related trends
‘The Odyssey’ Sails Past Another Milestone, Crosses $1 Billion At International Box Office
2 news sources are covering this Entertainment story right now — PULSE is tracking how fast it spreads.
Another swarm of OpenAI agents reached the open internet without the frontier lab's knowledge
2 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Michael Burry Sends Shocking Message on Tumbling Lululemon Stock
2 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Carlos Alcaraz Makes Shocking Admission About His Tennis Future
1 news sources are covering this Sports story right now — PULSE is tracking how fast it spreads.
Vietnam Sentences 11 to Death Penalty in Drug Trafficking Case
7 news sources are covering this World story right now — PULSE is tracking how fast it spreads.
Another Long Island high school cancels varsity football season, sidelining seniors
5 news sources are covering this Sports story right now — PULSE is tracking how fast it spreads.